Baxter Healthcare Corporation

FDA inspection history across 4 sites, 2001 to 2017

5
Warning letters
3
Close-outs
2
Form 483s

Every document, by year

  • Close-out
  • Form 483
  • Warning letter

2001: two warning letters; 2003: one warning letter; 2004: two warning letters; 2010: one Form 483; 2014: one Form 483; 2015: one close-out letter; 2017: two close-out letters.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2001–04Five warning letters, at Deerfield, Illinois and Westlake Village, California.
  2. 2010One Form 483, at Cleveland, Mississippi.
  3. 2014–17Three close-out letters and one Form 483, at Cleveland, Mississippi; Deerfield, Illinois and Irvine, California.
  4. 2014The longest 483 on file: 5 observations over 2 pages at Cleveland, Mississippi.

Cited most

Across all Baxter Healthcare observations on file

The complete Baxter Healthcare file.

All 10 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$743$990

25% off buying them one by one

Sites

Also: one document not tied to a site.

Documents

10 on file, newest first
DateDocumentPrice
2017-05-12Close-out Close-out letter$99
2017-02-08Close-out Close-out letter$99
2015-10-02Close-out Close-out letter$99
2014-01-23483 Form 483$99
2010-02-05483 Form 483$99
2004-05-25Warning letter Warning letter$99
2004-05-11Warning letter Warning letter$99
2003-04-02Warning letter Warning letter$99
2001-11-02Warning letter Warning letter$99
2001-08-22Warning letter Warning letter$99

Investigators on these documents

Marvin D. Jones (2)Thomas O. Morgan (1)

FEI number 1019003 · most recent document May 12, 2017

About Baxter Healthcare Corporation

How many FDA Form 483s has Baxter Healthcare Corporation received?

FDA Intel has 2 Form 483s on file for Baxter Healthcare Corporation; the most recent is dated Jan 23, 2014.

When was Baxter Healthcare Corporation last inspected by FDA?

The most recent FDA inspection document on file for Baxter Healthcare Corporation is a Form 483 dated Jan 23, 2014, for the site in Cleveland, Mississippi.

What did FDA cite at Baxter Healthcare Corporation?

The regulations cited most in the observations on file for Baxter Healthcare Corporation are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.22(a) (Responsibilities of quality control unit), 2 times; 21 CFR 211.165 (Testing and release for distribution), 1 time.

Has Baxter Healthcare Corporation received an FDA warning letter?

Yes. FDA Intel has 5 FDA warning letters on file for Baxter Healthcare Corporation; the most recent is dated May 25, 2004.